Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Minute Insights Ophthalmic Approvals

Minute Insight: iSTAR Medical Receives CE Mark For Glaucoma Device

  • News

Executive Summary

MINIject has been approved in Europe for open-angle glaucoma patients.

You may also be interested in...



Snapshot: May Highlights

A selection of articles you might have missed from May 2022, including exclusive interviews, an in depth discussion about China's rise to become one of the world's leaders in R&D, and the latest Rising Leaders interviews.

Minute Insight: Angle’s Parsortix Gets FDA Approval, Marking New Era For Liquid Biopsy

The FDA has approved Angle’s Parsortix circulating tumor cell cancer capturing system, which the company believes will be a paradigm shift for liquid biopsy in the US and heighten competition in the oncology diagnostics space.

Dexcom Rumored To Be In Talks To Acquire Insulet

Dexcom may be planning to purchase Insulet to enter the insulin pump market and transform itself into a diabetes tech giant.

Table

View full table

Topics

Related Companies

Tags:
Minute Insights Ophthalmic Approvals
UsernamePublicRestriction

Register

MT144731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By